ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)


Volume 17, 9 Issues, 2017


Download PDF Flyer

http://www.currentcancerdrugtargets.com/


Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Ruiwen Zhang


Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.992
5 - Year: 3.412
Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




Endorsement(s)

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets."

Paul Workman
CRC Centre for Cancer Therapeutics, England

Forthcoming Special Issue(s)

CANCER EPIGENETICS


Guest Editor(s): Aamir Ahmad
Tentative Publication Date: November, 2017
Submit Abstract via Email Download Description
Published Special Issue(s)

CANCER BIOMARKERS FROM BENCH TO BEDSIDE


Guest Editor(s): BALÁZS GYŐRFFY
Download Description
Authors' Comments
"I would like to express my sincere thanks for the services by Bentham Science.
I'm really happy with my submission in your Journal and hope that I will able to continue submitting manuscripts to your journal"

Saeed Samarghandian
(Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran)



Current Cancer Drug Targets

,

Volume 18

-

Number 1



Review Article

Lung Cancer Stem Cells: An Epigenetic Perspective

, 18(1): 16 - 31

Samriddhi Shukla, Sajid Khan, Sonam Sinha and Syed Musthapa Meeran*


DOI: 10.2174/1568009617666170206104623


Abstract PubMed Reprints Eprints Permissions




Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives


Lara Alessandrini, Tiziana Perin, Shahin Kadare, Lino del Pup, Lorenzo Memeo, Agostino Steffan, Lorenzo Colarossi, Massimiliano Berretta, Paolo De Paoli and Vincenzo Canzonieri*


View Abstract View on PubMed



Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling


Xinhua Xie, Xiaojia Huang, Hailin Tang, Feng Ye, Lu Yang, Xiaofang Guo, Zhi Tian, Cheng Peng* and Xiaoming Xie*


View Abstract View on PubMed



Ponatinib: A Review of Efficacy and Safety


Fulvio Massaro, Matteo Molica and Massimo Breccia*


View Abstract View on PubMed



Tunneling nanotubes: A versatile target for cancer therapy


Pragyaparamita Sahoo, Soumya Ranjan Jena and Luna Samanta*


View Abstract



Role of glioma-associated GLI1 oncogene in carcinogenesis and cancer-targeted therapy


Jie Wu, Dingxin Di, Chen Zhao, Yingyi Liu, Hongxia Chen, Yan Gong, Xianda Zhao and Honglei Chen*


View Abstract



AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer


Samanta Salvi*, Vincenza Conteduca, Cristian Lolli, Sara Testoni, Valentina Casadio, Andrea Zaccheroni, Lorena Rossi, Salvatore Luca Burgio, Cecilia Menna, Giuseppe Schepisi and Ugo De Giorgi


View Abstract



Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer

, 2017; 17(5): 479 - 485

Vinay K. Venishetty, Werner J. Geldenhuys, Tori B. Terell-Hall, Jessica I.G. Griffith, Gregory R. Sondag, Fayez F. Safadi and Paul R. Lockman*


DOI: 10.2174/1568009617666161121123948
Abstract PubMed Reprints Eprints Permissions



Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy

, 2017; 17(3): 236 - 254

Drew A. Spencer, Brenda M. Auffinger, Jason P. Murphy, Megan E. Muroski, Jian Qiao, Yureve Gorind and Maciej S. Lesniak


DOI: 10.2174/1568009616666161215161924
Abstract PubMed Reprints Eprints Permissions



Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?

, 2017; 17(1): 62 - 73

Sofia Braga, Joana Cardoso, Saudade Andre, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucilia Salgado, Sergio Dias, Jose B. Pereira-Leal and Jose Luis Passos-Coelho


DOI: 10.2174/1568009616666161025114914
Abstract PubMed Reprints Eprints Permissions



Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening

, 2016; 16(9): 818 - 828

Amit Sharma, Nidhi Jyotsana, Courteney K. Lai, Anuhar Chaturvedi, Razif Gabdoulline, Kerstin Görlich, Cecilia Murphy, Jan E. Blanchard, Arnold Ganser, Eric Brown, John A. Hassell, R. Keith Humphries, Michael Morgan and Michael Heuser


DOI: 10.2174/1568009616666160617103301
Abstract PubMed Reprints Eprints Permissions



Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science